ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $273,000 | -21.8% | 2,323 | -13.3% | 0.07% | +1.5% |
| Q1 2022 | $349,000 | -15.5% | 2,678 | -0.9% | 0.07% | -10.7% |
| Q4 2021 | $413,000 | -100.0% | 2,703 | -64.3% | 0.08% | -66.4% |
| Q1 2021 | $1,141,602,000 | +208.0% | 7,582 | +210.0% | 0.22% | +159.3% |
| Q4 2020 | $370,691,000 | +22.9% | 2,446 | +9.8% | 0.09% | 0.0% |
| Q3 2020 | $301,527,000 | -74.4% | 2,227 | -74.1% | 0.09% | -78.4% |
| Q2 2020 | $1,176,841,000 | +118.6% | 8,610 | +54.2% | 0.40% | +93.7% |
| Q4 2018 | $538,272,000 | -20.9% | 5,582 | 0.0% | 0.21% | -6.4% |
| Q3 2018 | $680,639,000 | +13.8% | 5,582 | +2.5% | 0.22% | +5.3% |
| Q2 2018 | $598,116,000 | +35.1% | 5,446 | +31.4% | 0.21% | +45.1% |
| Q1 2018 | $442,580,000 | +87.4% | 4,146 | +87.4% | 0.14% | +46.9% |
| Q4 2017 | $236,210,000 | -66.5% | 2,212 | +15.8% | 0.10% | -61.7% |
| Q2 2015 | $704,733,000 | +153.9% | 1,910 | +76.9% | 0.26% | +113.3% |
| Q2 2014 | $277,592,000 | – | 1,080 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |